- Home
- •
- For
For
How to Move Your Patent Application to the Front of the Line
Brett Trout If you have already filed a patent application, you likely want to get it examined as soon as possible. Fortunately, the United States Patent and Trademark Office (USPTO) has introduced a new option to help you do exactly that. In this post I will walk you through how to take advantage of this […]
Reddit’s Lawsuit Against AI Scrapers: What it Means for the Industry
Brett Trout If you are involved in content creation, AI development, or simply follow the big picture of the internet economy, the recent lawsuit filed by Reddit is something you should probably understand and follow. This lawsuit is about far more than one company suing another, it touches on who controls data, how AI gets […]
ChatGPT’s New Usage Policy: No More Legal or Medical Advice
Brett Trout ChatGPT just made a big change to its Usage Policy. As of October 29, 2025, OpenAI now prohibits users from using ChatGPT to give legal or medical advice. If you are relying on ChatGPT for help with court cases or medical conditions you are probably not reading this post, but if you are, […]
The Patent Office Issues New Rules On Patenting AI-Assisted Inventions
Brett Trout Artificial intelligence (AI) is transforming how inventions are created and how innovators seek protection in the United States. John Squires, Director of the United States Patent and Trademark Office (USPTO) recently issued updated guidance on how AI-assisted inventions are treated for inventorship in patent applications. This change is one of the most important developments for […]
What the New National AI Policy Means for Your Business
Brett Trout Back in October, I wrote about how states like California, Texas, Utah, and Colorado were punishing small businesses by implementing growing morass of disjointed mandatory state regulations on the use of AI. I wrote that what this country needs is not a hodge-podge of rent-seeking state regulations, but one clear national standard. This […]
Hims & Hers Abandons $49 Weight-Loss Pill Amidst Novo Nordisk Patent Infringement Lawsuit
Brett Trout In a major development shaking up the fast-growing weight-loss drug market, Hims & Hers Health has pulled its heavily discounted $49 compounded version of Wegovy, the blockbuster GLP-1 weight-loss pill from Novo Nordisk. This move followed mounting legal pressure from the Danish drugmaker.The decision has significant implications for intellectual property enforcement and competition in the […]